NEW YORK, N.Y. – Inogen will be added to the S&P SmallCap 600 stock market index after trading closes on Aug. 3. A company’s market capitalization must range from $400 million to $1.8 billion to be included in the S&P SmallCap 600 Index.
Elmsford, N.Y.-based BioScrip has extended the expiration date of its offer to exchange up to $200 million in aggregate principal amount of 8.875% senior notes due 2021. The offer will expire on June 16 instead of June 9 at 5 p.m.
Inogen has seen some traction from a private-label partnership with Applied Home Healthcare Equipment, company officials said during a conference call April 27 to discuss fourth quarter and full year earnings.
GOLETA, Calif. – Say what you will about Inogen’s direct-to-consumer business model—it’s the business-to-business segment that continued to lead the company’s growth in the first quarter of 2015.
GOLETA, Calif. – Inogen reported double-digit increases in sales and revenues for first quarter of 2015—a “solid start,” says Ray Huggenberger, president and CEO.
GOLETA, Calif. – Inogen has received a notice from the NASDAQ stating it’s not in compliance with a rule requiring timely filing of periodic financial reports with the Securities and Exchange Commission.
